Similar articles

• Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.

  Tomio J, Yamana H, Matsui H, Yamashita H, Yoshiyama T, Yasunaga H. Tomio J, et al. Int J Rheum Dis. 2017 Nov;20(11):1674-1683. doi: 10.1111/1756-185X.13190. Epub 2017 Oct 26. Int J Rheum Dis. 2017. PMID: 29076252
• Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.

  Pourakbari B, Yousefi K, Mahmoudi S, Sadeghi RH, Mamishi S. Pourakbari B, et al. Infect Disord Drug Targets. 2019;19(2):141-144. doi: 10.2174/1871526518666180228164036. Infect Disord Drug Targets. 2019. PMID: 29493468
• Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.

  Costantino F, de Carvalho Bittencourt M, Rat AC, Loeuille D, Dintinger H, Béné MC, Faure G, Chary-Valckenaere I. Costantino F, et al. J Rheumatol. 2013 Dec;40(12):1986-93. doi: 10.3899/jrheum.130303. Epub 2013 Oct 1. J Rheumatol. 2013. PMID: 24085550 Clinical Trial.
• Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.

  Goletti D, Sanduzzi A, Delogu G. Goletti D, et al. J Rheumatol Suppl. 2014 May;91:24-31. doi: 10.3899/jrheum.140099. J Rheumatol Suppl. 2014. PMID: 24788997 Review.
• IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.

  Nienhaus A, Ringshausen FC, Costa JT, Schablon A, Tripodi D. Nienhaus A, et al. Expert Rev Anti Infect Ther. 2013 Jan;11(1):37-48. doi: 10.1586/eri.12.150. Expert Rev Anti Infect Ther. 2013. PMID: 23428101 Review.